Avista Healthcare Partners, a private equity firm focused exclusively on healthcare, has announced its acquisition of EBI, the bone healing division of Highridge Medical.
Headquartered in Parsippany, New Jersey, EBI is focused on electrobiology innovations and has a large portfolio of clinically proven, safe and effective implantable and non-invasive bone growth stimulation solutions to support bone regeneration and healing outcomes.
Founded in 2005, Avista Healthcare Partners (formerly Avista Capital Partners) is a New York-based private equity firm with more than $9 billion invested in more than 50 growth-oriented healthcare businesses globally.
The acquisition marks the 50th platform healthcare investment for Avista, according to the original deal press release from June 4, 2025. Kevin Kenny, an Avista Strategic Executive, joined EBI as Chief Executive Officer at closing. Ropes & Gray LLP acted as legal advisor to Avista. Financial terms of the deal were not disclosed.
According to data captured in the LevinPro HC database, this marks the 40th Medical Device transaction of 2025. Other private equity firms that have made acquisitions in the Medical Device space this year have been Ampersand Capital Partners, SK Capital Partners, Investindustrial, AGIC Capital, NORD Holding, Viscogliosi Brothers, LLC and Montagu Private Equity. There were 87 Medical Device acquisitions announced during 2024, 112 announced in 2023 and 124 announced during 2022.
